Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) reported Q2 2017 earnings this Afternoon, coming in at $0.15 per share, in-line Wall Street’s estimates of $0.15 per Share. Revenue for the quarter came in at $426.10 million beating analyst estimates of $424.94 million
Analyst Coverage For Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)
These are 1 Sell Rating, 8 Hold Ratings, 9 Buy Ratings .
The current consensus rating for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) is Hold (Score: 2.44) with a consensus target price of $14.50 , a potential (24.25% upside)Recent Insider Trading for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)
- On 5/16/2017 Richard J Poulton, President, sold 25,000 with an average share price of $12.06 per share and the total transaction amounting to $301,500.00.
- On 3/23/2017 Brian Farley, SVP, sold 15,000 with an average share price of $11.63 per share and the total transaction amounting to $174,450.00.
- On 9/15/2016 James Hewitt, SVP, sold 17,500 with an average share price of $13.00 per share and the total transaction amounting to $227,500.00.
- On 9/15/2016 Paul Black, CEO, sold 15,000 with an average share price of $13.00 per share and the total transaction amounting to $195,000.00.
- On 7/11/2016 Dennis Olis, SVP, sold 7,000 with an average share price of $14.00 per share and the total transaction amounting to $98,000.00.
- On 7/1/2016 James Hewitt, SVP, sold 17,500 with an average share price of $13.00 per share and the total transaction amounting to $227,500.00.
Recent Trading for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Shares of Allscripts Healthcare Solutions, Inc. closed the previous trading session at 11.67 down -0.25 -2.10% with 3,424,112 shares trading hands.